MUHAMMAD AZIZ: Open Payments
NPI 1437152873 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 17 payments from 5 companies in 2025. Trend: 2023 $282 · 2024 $218 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $148 |
| PFIZER INC. | 4 | $85 |
| Novo Nordisk Inc | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: ELIQUIS, VRAYLAR, QULIPTA, UBRELVY, Ozempic, FARXIGA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
